Editor's Picks

There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.

Boston Scientific

Boston Scientific

  1. Earnings Preview: Medtronic - Analyst Blog
    NASDAQ 1 day ago

    This situation is taking its toll across the industry as reflected in the recently reported results of Medtronic's peers, Boston Scientific ( BSX ) and St Jude Medical ( STJ ). Moreover, the Spinal segment is also witnessing several headwinds such as...

  2. Why Agency Fraud Is Like Fraud On The FDA
    Drug and Device Law 1 day ago

    In our rather terse (due to firm involvement) post on Monday concerning Merck & Co. v. Ratliff, ___ S.W.3d ___, 2012 WL 413522 (Ky. App. Feb. 10, 2012) – beating both BNA and 360 by two days, BTW – we mentioned the “interesting” aspects of that case. ...

  3. AP Photo logo AP Photo 5 months ago
    This undated photo provided by Boston Scientific Corp. , shows Michael Mahoney who will appointed president of Boston Scientific Corp. , Oct. 17, 2011. Boston Scientific Corp.'s choice of Johnson & Johnson executive Michael Mahoney to become its next...

    This undated photo provided by Boston Scientific Corp. , shows Michael Mahoney who will appointed president of Boston Scientific Corp. , Oct. 17, 2011. Boston Scientific Corp.'s choice of Johnson & Johnson executive Michael Mahoney to become its next... View Photo »

  4. The Epic Stent is a novel stent platform designed to offer both acute and clinical advantages over older-generation stent systems. Upon approval, the Epic Stent along with the market-leading Express® LD balloon-expandable iliac stent, would enable Boston Scientific to offer a complete line of advanced i...
    SOURCE: Street Insider 1 month ago
  5. Boston Scientific Bulls Angle for Rebound
    The Street logo The Street 1 day ago

    The medical-device company's stock rose 1.36% Thursday to close at $5.97. The slow-moving shares rallied from a long-term low of $5 to $6 between mid-December and mid-January and have been consolidating since then. OptionMonster's tracking systems show...

  6. Option Bulls Expect a Rebound in Boston Scientific
    CNBC logo CNBC 1 day ago

    Boston Scientific [ BSX 5.97 +0.08 (+1.36%) ] rose 1.36 percent yesterday to close at $5.97. Shares of the slow-moving medical-device company rallied from a long-term low of $5 to $6 between mid-December and mid-January and have been consolidating...

  7. Endoscopic Bariatric Therapies Gain Traction With Expert Paper
    Gastroenterology and Endoscopy News 2 days ago
    NULL

    BARD, Covidien and Hour-Glass, and has an advisory role and consultant position for Ethicon Endo-Surgery. Dr. Nguyen is a consultant to Covidien, Ethicon and Reshape Medical. Dr. Pryor has an ownership interest in BaroSense and TransEnterix; has...

  8. We estimate Quad-Pole technology from Medtronic Inc. (MDT) and Boston Scientific Corp. (BSX) are at least one to two years behind Quartet, so St. Jude has a meaningful lead
    SOURCE: Bloomberg.com 2 months ago
  9. Boston Scientific
    YouTube Logo YouTube Videos 11 months ago
  10. Taxing Medical Progress to Death
    Real Clear Politics logo Real Clear Politics 2 days ago

    It was a timely reminder about the dangers of stifling private-sector medical innovation. No one listened. Stents don't grow on trees. They were not created, developed, marketed or sold by government bureaucrats and lawmakers. One of the nation's top...

  11. New Michelle Malkin for 02/27/2012
    Creators Syndicate logo Creators Syndicate 2 days ago

    It was a timely reminder about the dangers of stifling private-sector medical innovation. No one listened. Stents don't grow on trees. They were not created, developed, marketed or sold by government bureaucrats and lawmakers. One of the nation's top...

(What's this?)
  1. Are you a Publisher?

    We built Daylife.com using Daylife platform, which helps you be more efficient and creative with content. It's designed for publishers, editors, and developers to build better content-based sites, services, and apps for clients and audiences. Learn More »

About Boston Scientific

Wikipedia

The Boston Scientific Corporation (NYSE: BSX) (abbreviated BSC), is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a range of interventional medical specialties, including interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery,... Full Article

Related Photos

Related Topics

  1. Food and Drug Administration Food and Drug Administration
  2. NYSE NYSE
  3. Medtronic, Inc. Medtronic, Inc.
  4. Stryker Corporation Stryker Corporation
  5. Johnson & Johnson Johnson & Johnson
  6. Detroit Medical Center Detroit Medical Center

Timeline of Coverage

  1. Click to see all coverage from Jan 03, 2012
    2
    January 03, 2012
  2. Click to see all coverage from Jan 04, 2012
    5
    January 04, 2012
  3. Click to see all coverage from Jan 05, 2012
    10
    January 05, 2012
  4. Click to see all coverage from Jan 06, 2012
    0
    January 06, 2012
  5. Click to see all coverage from Jan 07, 2012
    0
    January 07, 2012
  6. Click to see all coverage from Jan 08, 2012
    0
    January 08, 2012
  7. Click to see all coverage from Jan 09, 2012
    1
    January 09, 2012
  8. Click to see all coverage from Jan 10, 2012
    1
    January 10, 2012
  9. Click to see all coverage from Jan 11, 2012
    2
    January 11, 2012
  10. Click to see all coverage from Jan 12, 2012
    5
    January 12, 2012
  11. Click to see all coverage from Jan 13, 2012
    0
    January 13, 2012
  12. Click to see all coverage from Jan 14, 2012
    0
    January 14, 2012
  13. Click to see all coverage from Jan 15, 2012
    0
    January 15, 2012
  14. Click to see all coverage from Jan 16, 2012
    2
    January 16, 2012
  15. Click to see all coverage from Jan 17, 2012
    8
    January 17, 2012
  16. Click to see all coverage from Jan 18, 2012
    1
    January 18, 2012
  17. Click to see all coverage from Jan 19, 2012
    0
    January 19, 2012
  18. Click to see all coverage from Jan 20, 2012
    2
    January 20, 2012
  19. Click to see all coverage from Jan 21, 2012
    2
    January 21, 2012
  20. Click to see all coverage from Jan 22, 2012
    0
    January 22, 2012
  21. Click to see all coverage from Jan 23, 2012
    11
    January 23, 2012
  22. Click to see all coverage from Jan 24, 2012
    2
    January 24, 2012
  23. Click to see all coverage from Jan 25, 2012
    18
    January 25, 2012
  24. Click to see all coverage from Jan 26, 2012
    2
    January 26, 2012
  25. Click to see all coverage from Jan 27, 2012
    1
    January 27, 2012
  26. Click to see all coverage from Jan 28, 2012
    0
    January 28, 2012
  27. Click to see all coverage from Jan 29, 2012
    0
    January 29, 2012
  28. Click to see all coverage from Jan 30, 2012
    6
    January 30, 2012
  29. Click to see all coverage from Jan 31, 2012
    3
    January 31, 2012
  30. Click to see all coverage from Feb 01, 2012
    7
    February 01, 2012
  31. Click to see all coverage from Feb 02, 2012
    27
    February 02, 2012
  32. Click to see all coverage from Feb 03, 2012
    7
    February 03, 2012
  33. Click to see all coverage from Feb 04, 2012
    0
    February 04, 2012
  34. Click to see all coverage from Feb 05, 2012
    0
    February 05, 2012
  35. Click to see all coverage from Feb 06, 2012
    3
    February 06, 2012
  36. Click to see all coverage from Feb 07, 2012
    6
    February 07, 2012
  37. Click to see all coverage from Feb 08, 2012
    5
    February 08, 2012
  38. Click to see all coverage from Feb 09, 2012
    2
    February 09, 2012
  39. Click to see all coverage from Feb 10, 2012
    0
    February 10, 2012
  40. Click to see all coverage from Feb 11, 2012
    0
    February 11, 2012
  41. Click to see all coverage from Feb 12, 2012
    0
    February 12, 2012
  42. Click to see all coverage from Feb 13, 2012
    6
    February 13, 2012
  43. Click to see all coverage from Feb 14, 2012
    1
    February 14, 2012
  44. Click to see all coverage from Feb 15, 2012
    3
    February 15, 2012
  45. Click to see all coverage from Feb 16, 2012
    0
    February 16, 2012
  46. Click to see all coverage from Feb 17, 2012
    4
    February 17, 2012
  47. Click to see all coverage from Feb 18, 2012
    0
    February 18, 2012
  48. Click to see all coverage from Feb 19, 2012
    0
    February 19, 2012

Related Videos

  1. Videosurf
    1. Boston Scientific to Pay Johnson & Johnson $1.73B Settlement
      Boston Scientific to Pay Johnson & Johnson $1.7...
      24 months ago
    2. closing bell : Inside Boston Scientific's Transition
      closing bell : Inside Boston Scientific's Trans...
      1 month ago
    3. Inside Boston Scientific's Transition
      Inside Boston Scientific's Transition
      1 month ago
    4. Boston Scientific Co. announces results from MADIT-CRT trial
      Boston Scientific Co. announces results from MA...
    5. Boston Scientific Bids for Guidant
      Boston Scientific Bids for Guidant
      47 months ago
    6. Boston Scientific/JNJ/Guidant Bidding Wars
      Boston Scientific/JNJ/Guidant Bidding Wars
      74 months ago
    View All Videosurf Videos »

Related Quotes

  • Previous
  • Next
  • 1/6
  1. The Epic Stent is a novel stent platform designed to offer both acute and clinical advantages over older-generation stent systems. Upon approval, the Epic Stent along with the market-leading Express® LD balloon-expandable iliac stent, would enable Boston Scientific to offer a complete line of advanced i...
    SOURCE: Street Insider 1 month ago
  2. We estimate Quad-Pole technology from Medtronic Inc. (MDT) and Boston Scientific Corp. (BSX) are at least one to two years behind Quartet, so St. Jude has a meaningful lead
    SOURCE: Bloomberg.com 2 months ago
  3. This should be a strong positive for St Jude’s CRT-D business, and when combined with the accelerating replacement cycle should allow the company to continue to take share from competitors Boston Scientific and Medtronic – the European experience has been positive.
    SOURCE: Med City News 2 months ago
  4. This approval marks an important milestone for Boston Scientific — the beginning of a transition to higher margins on our everolimus stent offering in the U.S. as we shift from the PROMUS Stent to the internally manufactured PROMUS Element Plus Stent System
    SOURCE: PR Newswire 2 months ago
  5. While we continue to watch this issue closely, we think that the Promus Element approval may indicate that FDA is not overly concerned about longitudinal compression ... We continue to believe that Boston Scientific is in the early stages of a turnaround in terms of both revenue growth and margins. The ...
    SOURCE: Reuters Mobile 2 months ago
  6. FDA is actively working with (drug-eluting stent) manufacturers, including Boston Scientific, to better understand longitudinal stent deformation with respect to its causes, predisposing underlying anatomic conditions, operator techniques that can reduce the likelihood of its occurrence, and treatment s...
    SOURCE: Press TV 2 months ago
View All »